PWMG
NBIX icon

Private Wealth Management Group’s Neurocrine Biosciences NBIX Stock Holding History

Private Wealth Management Group’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Hold
83
– – ﹤0.01% 496
2025
Q4 		$11.8K Sell
83
-3
-3% -$435 ﹤0.01% 466
2025
Q3 		$12.1K Hold
86
– – ﹤0.01% 460
2025
Q2 		$10.8K Buy
86
+58
+207% +$6.65K ﹤0.01% 463
2025
Q1 		$3.1K Sell
28
-58
-67% -$7.35K ﹤0.01% 905
2024
Q4 		$11.7K Buy
86
+59
+219% +$7.3K ﹤0.01% 425
2024
Q3 		$3.11K Sell
27
-44
-62% -$6.03K ﹤0.01% 906
2024
Q2 		$9.78K Buy
71
+44
+163% +$6.03K ﹤0.01% 446
2024
Q1 		$3.72K Hold
27
– – ﹤0.01% 727
2023
Q4 		$3.56K Buy
+27
New +$3.11K ﹤0.01% 745

Other funds holding NBIX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return